Sign In
Buy HOOK
$1.15
+0 (+0%)
At Close: Jun 03, 2026
HOOKIPA Announces Issuance of US and European Patents
11:00am, Monday, 03'rd Aug 2020
NEW YORK and VIENNA, Austria, Aug. 03, 2020 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases
Royal Bank of Canada Has $68,000 Stake in Hookipa Pharma Inc (NASDAQ:HOOK)
04:56am, Monday, 03'rd Aug 2020
Royal Bank of Canada increased its position in Hookipa Pharma Inc (NASDAQ:HOOK) by 81.6% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 8,253 shares of the
Could The HOOKIPA Pharma Inc. (NASDAQ:HOOK) Ownership Structure Tell Us Something Useful?
07:24pm, Thursday, 23'rd Jul 2020
A look at the shareholders of HOOKIPA Pharma Inc. (NASDAQ:HOOK) can tell us which group is most powerful. Institutions...
Fauci says U.S. needs to 'get better control' of the coronavirus to reopen without outbreaks
05:43pm, Friday, 17'th Jul 2020
Dr. Anthony Fauci said Friday that the coronavirus has hit the U.S. "very severely" and the country "needs to get better control over things" in order to reopen the economy and head toward normality.
Steroid's COVID-19 benefits confirmed; spotlight on immune cells
12:00am, Friday, 17'th Jul 2020
Steroid's COVID-19 benefits confirmed; spotlight on immune cells
Evelo Trial Progress, And Other News: The Good, Bad And Ugly Of Biopharma
02:18am, Wednesday, 24'th Jun 2020
Evelo Biosciences proceeds with midstage trial of EDP1815. HOOKIPA reports positive data for HB-101. Theratechnologies reports positive data.
HOOKIPA PHARMA INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K) | MarketScreener
11:26am, Monday, 22'nd Jun 2020HOOKIPA Announces Positive Phase 2 Interim Safety and Immunogenicity Results for its CMV Vaccine Candidate HB‑101
11:15am, Monday, 22'nd Jun 2020
HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today
From Golly Bars to Eskimo Mints: The Irish brands with a race problem
05:00am, Monday, 22'nd Jun 2020
US firms are ditching racist branding. But Ireland has had its share of offensive products
HOOKIPA Announces Changes to its Board of Directors – Resignation of Sander van Deventer
11:00am, Friday, 19'th Jun 2020
NEW YORK and VIENNA, Austria, June 19, 2020 -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics targeting infectious.
HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers
11:00am, Wednesday, 17'th Jun 2020
HOOKIPA Pharma Inc. (HOOK), a company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform, today announced that the U.S.
Could Gilead Sciences Have an HIV Cure Waiting in the Wings? | The Motley Fool
11:03am, Sunday, 14'th Jun 2020
Treating COVID-19 is great. But the real game-changer for Gilead could be in curing HIV.
Hedge Funds Are Selling HOOKIPA Pharma Inc. (HOOK)
06:04pm, Friday, 12'th Jun 2020
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and succes
